Tag: Dicerna Pharmaceuticals Inc

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Dicerna Pharmaceuticals Inc

Dicerna Announces Boehringer Ingelheim's Acceptance of Candidate for Development Under ...

Added to Collection on: 2021-05-24 11:26:15

Tags for this article:

Nucleic acids
Branches of biology
RNA
Hepatitis
Gene expression
Molecular genetics
RNA interference
Boehringer Ingelheim
Non-alcoholic fatty liver disease
Alnylam Pharmaceuticals
Eli Lilly and Company
Dicer
Dicerna Pharmaceuticals Inc

Click the tags to see associated articles and topics

View Article Details
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Insider Regina M. Paglia Sells 4431 Shares

Added to Collection on: 2021-06-04 12:56:15

Tags for this article:

Financial markets
Financial economics
Finance
Corporate finance
Stock
Stock market
Short
Dicerna Pharmaceuticals Inc

Click the tags to see associated articles and topics

View Article Details
Zacks: Analysts Anticipate Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) to Post $0.51 EPS

Added to Collection on: 2021-06-04 21:33:45

Tags for this article:

Financial markets
Finance
Financial economics
Corporate finance
Stock
Stock market
Short
Price?earnings ratio
Dicerna Pharmaceuticals Inc

Click the tags to see associated articles and topics

View Article Details
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Expected to Post Quarterly Sales of $129.44 Million

Added to Collection on: 2021-06-04 21:39:50

Tags for this article:

Life Sciences
Financial markets
Health care
Corporate finance
Stock
Stock market
Pharmaceutical industry in China
Dicerna Pharmaceuticals Inc
Zacks

Click the tags to see associated articles and topics

View Article Details
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Receives Consensus Rating of "Buy" from ...

Added to Collection on: 2021-06-15 13:30:00

Tags for this article:

Financial markets
Finance
Financial economics
Equity securities
Stock market
Corporate finance
Stock
Short
Share
NASDAQ
Dicerna Pharmaceuticals Inc

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax ...

Added to Collection on: 2021-06-15 12:07:43

Tags for this article:

Life Sciences
Companies
Industry economics)
Medical research
NASDAQ
Biogen
Novavax
AstraZeneca
COVID-19 vaccine
Vertex Pharmaceuticals
NASDAQ-100
Protagonist Therapeutics Inc
ResMed Inc.
Maravai LifeSciences Holdings, Inc.
DR.REDDY'S LABORATORIES LIMITED
Enochian Biosciences Inc.
Sesen Bio Inc.
Alkermes Plc
GT Biopharma Inc.
Centessa Pharmaceuticals Limited
Jazz Pharmaceuticals PLC
RDY Edwards Lifesciences Corporation
Verastem Inc.
Dicerna Pharmaceuticals Inc
LeMaitre Vascular Inc.
Zoetis Inc.
PPD, Inc.
Apellis Pharmaceuticals Inc.
NovoCure Limited
RAPT Therapeutics Inc.
Ortho Clinical Diagnostics Holdings plc
Koninklijke Philips NV
Psychemedics Corporation
Shockwave Medical Inc
Bio-Techne Corporation

Click the tags to see associated articles and topics

View Article Details
Regina M. Paglia Sells 1000 Shares of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Stock

Added to Collection on: 2021-06-25 02:30:05

Tags for this article:

Finance
Financial markets
Money
Pharmaceutical industry in China
Pharmaceuticals policy
Pharmacy in China
Science and technology in the People's Republic of China
Stock
Short
Dicerna Pharmaceuticals Inc

Click the tags to see associated articles and topics

View Article Details
Zacks: Analysts Expect Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Will Announce Earnings of ...

Added to Collection on: 2021-07-10 13:18:52

Tags for this article:

Finance
Money
Economy
Valuation
Financial regulation
Short
Stock
Price?earnings ratio
Financial analyst
Securities research
Martin Shkreli
Dicerna Pharmaceuticals Inc

Click the tags to see associated articles and topics

View Article Details
Should You Expect Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA) To Recover From Its 56.58 ...

Added to Collection on: 2021-07-17 15:22:30

Tags for this article:

Financial markets
Finance
Money
Stock market
Equity securities
Corporate finance
Dividend yield
Stock
Share
NASDAQ
Dividend
SPDR
Dicerna Pharmaceuticals Inc

Click the tags to see associated articles and topics

View Article Details
Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA) Jumps 0.97%, But Further Rally Could Be Imminent

Added to Collection on: 2021-07-31 19:52:30

Tags for this article:

Financial markets
Stock market
Finance
Financial economics
Equity securities
Corporate finance
Stock
Short
Share
Fundamental analysis
Initial public offering
NASDAQ
Dicerna Pharmaceuticals Inc

Click the tags to see associated articles and topics

View Article Details